Bipolar Disorder, Part II: The Novel Anticonvulsants (September)

Date of Issue: 09/01/2003 | Volume: 1 | Number: 9

Issue Links:

Lamictal (lamotrigine) has been approved! The only problem is that few people can quite comprehend what it’s been approved for.

In This Issue

Article

Lamictal: Miraculous? Not Quite

Lamictal (lamotrigine) has been approved! The only problem is that few people can quite comprehend what it's been approved for.

Read More
Article

Topamax: Weight Loss Plus

Topamax (topiramate), oddly enough, is a derivative of fructose. It is strange that one of the very few psychotropics to cause weight loss is closely related to sugar, but there you have it. It is only approved as adjunctive therapy for seizure treatment by the FDA.

Read More
Article

Trileptal: Everyone’s Using It!

Topics: Bipolar Disorder

Suddenly, we all have a colleague who is prescribing Trileptal (oxcarbazepine) for bipolar disorder, and who is claiming to have fabulous success.

Read More
Expert Q&A

Dr. Claudia Baldassano on Interviewing Tips in Bipolar Disorder

Topics: Bipolar Disorder | Practice Tools and Tips

Dr. Baldassano, as the Director of the Bipolar Outpatient Clinic of U Penn, how many patients with bipolar disorder do you typically evaluate in a given week?

Read More
Tales from The History Of Psychiatry

The Father of Bipolar Disorder

In the late 1800’s, the German psychiatrist Emil Kraepelin was unhappy with the primitive state of psychiatric diagnosis. So he set up shop at the Heidelberg Clinic and proceeded to study hundreds of patients longitudinally.

Read More